Trending...
- 7-Year Old Singer/Songwriter Kyra Pesebre Releases "I Love You, Dad" In Time For Father's Day - 452
- Waterside Productions Announces Said E. Dawlabani's New Book "The Light of Ishtar"
- Paul Sinacore Casting Shines Spotlight On "Friends: The Reunion" as Diversity Backlash Continues
SAN DIEGO, May 11, 2021 /PRNewswire/ -- Neurana Pharmaceuticals, a biotechnology company focused on the treatment of neuromuscular conditions, today announced that Randall Kaye, Chief Medical Officer, will present at the 21st Annual Pain Therapeutics Conference. The conference takes place virtually May 10-11th. Presentations will be available for registered attendees via the conference website.
About Neurana Pharmaceuticals, Inc.
Neurana Pharmaceuticals, Inc. is a privately held, clinical-stage, biotechnology company focused on the treatment of neuromuscular conditions, including acute, painful muscle spasms of the back. The company was founded in 2013 and is based in San Diego. Neurana's lead development compound is tolperisone, a novel, non-opioid, non-drowsy, non-cognitive impairing treatment, which the company is developing for the large population of patients who experience muscle spasms. In May 2018, Neurana completed a $60 million Series A financing led by Sofinnova Ventures with participation from Longitude Capital, New Leaf Venture Partners and H.I.G. BioHealth Partners to fund the clinical development of tolperisone. For additional information, please visit www.neuranapharma.com.
More on The Californer
SOURCE Neurana Pharmaceuticals, Inc.
Related Links
http://www.neuranapharma.com
About Neurana Pharmaceuticals, Inc.
Neurana Pharmaceuticals, Inc. is a privately held, clinical-stage, biotechnology company focused on the treatment of neuromuscular conditions, including acute, painful muscle spasms of the back. The company was founded in 2013 and is based in San Diego. Neurana's lead development compound is tolperisone, a novel, non-opioid, non-drowsy, non-cognitive impairing treatment, which the company is developing for the large population of patients who experience muscle spasms. In May 2018, Neurana completed a $60 million Series A financing led by Sofinnova Ventures with participation from Longitude Capital, New Leaf Venture Partners and H.I.G. BioHealth Partners to fund the clinical development of tolperisone. For additional information, please visit www.neuranapharma.com.
More on The Californer
- Edison International Declares Q2 Dividends
- San Jose: FLASH REPORT #165 - COVID-19 Response and Recovery
- San Jose Mayor, City Council Unanimously Approve Acting City Manager for 10th Largest City in the Nation
- Confluent Announces Pricing of Initial Public Offering
- Cryptsoft's KMIP technology strengthens security in Networked Energy Services' Advanced Metering Infrastructure solutions
SOURCE Neurana Pharmaceuticals, Inc.
Related Links
http://www.neuranapharma.com
Filed Under: Business
0 Comments
Latest on The Californer
- PEAK Technical Services Selects ELEVATE to Manage Portfolio of Mid-Market MSP Customers
- Revolution Entertainment Services Announces New Production Budgeting Platform, TrueBudget
- The Tokelor | Sponsors Announced
- Puppet Up! - Uncensored Returns! The Jim Henson Company's charlie Chaplin Soundstage is Open for four special Performances of The Acclaimed Henson Alternative live Show
- Syxsense Extends Enterprise Integration with Secure API
- San Francisco Department of Public Health and San Francisco Giants Join Together to Encourage All Eligible Residents to Get Vaccinated Against COVID-19
- AHF: Six Reasons Why WHO Chief Should Go
- Steven E. Otto Joins Crosbie Gliner Schiffman Southard & Swanson LLP (CGS3) as Partner
- HUP.LIFE & Etho Protocol Join Forces To Deliver First Decentralized NFT Solution
- Clean Vision's Subsidiary Clean-Seas Signs Binding MOU with Plastic Waste-to-Energy Technology Group Global Green Int'l Investments
- From Berkshire to Hollywood: 1950s Style Seamed Stockings by Retro Lingerie Brand What Katie Did
- Fund Street Technologies Brand Named One of Florida's 'Best Companies To Work For' for the 2nd Time
- RealTrends + Tom Ferry Announce 2021 America's Best Real Estate Professionals List 16th Annual Real Estate Ranking
- El Dorado County ESA Chooses IQ Mobile Software for Faster Emergency Response
- Autism's Got Talent Announces the 2nd Annual On-Line Talent Fundraiser Competition
- Hims & Hers Expands Hair Growth Offerings with Launch of Minoxidil 5% Foam
- Gamma Zeta Boulé Foundation Raises $190,000, Awards $83,000 in Scholarships to Eight Graduating Senior L.A.M.P. Mentor Program Mentees and Recognizes Three L.A.M.P. Mentees Selected as Boulé Scholars
- AdsWizz New Audio Attribution Solution Delivers Positive Results for Advertisers
- Cloud Gaming Market Size To Expand At 48.2% CAGR By 2027, Owing To Rising Investments In 5G Technology & Admittance To Several Games On Cloud At Reasonable Prices | Million Insights
- Infogain Recognized as 2nd Fastest Growing Company in Everest Group Engineering Services Top 50™ 2021